This week: Recent Advances in Solar-Driven Carbon Dioxide Conversion Each and every day, ACS grants free access to a new peer-reviewed research article from one of the Society’s journals. These articles are specially chosen by a team of scientific editors of ACS journals from around the world to highlight the transformative power of chemistry. Access […]

This week: Recent Advances in Solar-Driven Carbon Dioxide Conversion

Each and every day, ACS grants free access to a new peer-reviewed research article from one of the Society’s journals. These articles are specially chosen by a team of scientific editors of ACS journals from around the world to highlight the transformative power of chemistry. Access to these articles will remain open to all as a public service.

Check out this week’s picks!
***
Novel Biorefinery Approach Aimed at Vegetarians Reduces the Dependency on Marine Fish Stocks for Obtaining Squalene and Docosahexaenoic Acid
ACS Sustainable Chem. Eng. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acssuschemeng.0c02752
***
Three Birds with One Stone: Injectable CaC2 Nanobombs with Triple Effects for Minimally Invasive Tumor Chemical Ablation
ACS Appl. Bio Mater. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acsabm.0c00383
***
Recent Advances in Solar-Driven Carbon Dioxide Conversion: Expectations versus Reality
ACS Energy Lett. 2020, 5, 6, 1996–2014
DOI: 10.1021/acsenergylett.0c00645
***
Synthesis, Structure, and Optical Properties of Di-m-benzihexaphyrins (1.1.0.0.0.0) and Di-m-benziheptaphyrins (1.0.1.0.0.0.0): Blackening of m-Phenylene-Linked Dicarbaporphyrinoids by Simple π-Expansion
J. Org. Chem. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acs.joc.0c00754
***
Mechanisms of Thermal Atomic Layer Etching
Acc. Chem. Res. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acs.accounts.0c00084
***
Hypocrellin-Based Multifunctional Phototheranostic Agent for NIR-Triggered Targeted Chemo/Photodynamic/Photothermal Synergistic Therapy against Glioblastoma
ACS Appl. Bio Mater. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acsabm.0c00386
***
Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency Reversal
ACS Infect. Dis. 2020, XXXX, XXX, XXX-XXX
DOI: 10.1021/acsinfecdis.9b00514
***
Love ACS Editors’ Choice? Get a weekly e-mail of the latest ACS Editor’s Choice articles and never miss a breakthrough!

Want the latest stories delivered to your inbox each month?